{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T06:11:36Z","timestamp":1793772696670,"version":"4.6.1"},"reference-count":52,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Burns"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.burns.2025.107518","type":"journal-article","created":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T02:52:00Z","timestamp":1745290320000},"page":"107518","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Effect of early administration of inhaled heparin on outcomes of smoke inhalation injury: A randomized controlled trial"],"prefix":"10.1016","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1900-0353","authenticated-orcid":false,"given":"Sameh M.","family":"Hakim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariam N.","family":"Fouad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariam K.","family":"Habib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-0949-3490","authenticated-orcid":false,"given":"Mahmoud S.","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0967-2463","authenticated-orcid":false,"given":"Safaa I.","family":"Ghaly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.burns.2025.107518_bib1","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/S0140-6736(16)31458-1","article-title":"Pathophysiology, research challenges, and clinical management of smoke inhalation injury","volume":"388","author":"Enkhbaatar","year":"2016","journal-title":"Lancet"},{"issue":"3 2","key":"10.1016\/j.burns.2025.107518_bib2","doi-asserted-by":"crossref","first-page":"S98","DOI":"10.1097\/SAP.0000000000001377","article-title":"Inhalation injury in the burned patient","volume":"80","author":"Foncerrada","year":"2018","journal-title":"Ann Plast Surg"},{"key":"10.1016\/j.burns.2025.107518_bib3","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1111\/jth.13283","article-title":"Coagulopathy and its management in patients with severe burns","volume":"14","author":"Glas","year":"2016","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.burns.2025.107518_bib4","doi-asserted-by":"crossref","first-page":"180","DOI":"10.4103\/ijccm.IJCCM_460_17","article-title":"Smoke inhalation injury: etiopathogenesis, diagnosis, and management","volume":"22","author":"Gupta","year":"2018","journal-title":"Indian J Crit Care Med"},{"key":"10.1016\/j.burns.2025.107518_bib5","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/00003246-198201000-00006","article-title":"Respiratory changes after major burn injury","volume":"10","author":"Nishimura","year":"1982","journal-title":"Crit Care Med"},{"key":"10.1016\/j.burns.2025.107518_bib6","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1007\/s00268-002-4063-3","article-title":"Mechanisms of pulmonary microvascular dysfunction during severe burn injury","volume":"26","author":"Turnage","year":"2002","journal-title":"World J Surg"},{"key":"10.1016\/j.burns.2025.107518_bib7","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0305-4179(00)00130-3","article-title":"Heparin in the treatment of burns: a review","volume":"27","author":"Saliba","year":"2001","journal-title":"Burns"},{"key":"10.1016\/j.burns.2025.107518_bib8","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1089\/jamp.2015.1273","article-title":"Inhaled heparin: therapeutic efficacy and recent formulations","volume":"30","author":"Yildiz-Pekoz","year":"2017","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"key":"10.1016\/j.burns.2025.107518_bib9","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1055\/s-0040-1721319","article-title":"Heparin Inhibits Cellular Invasion by SARS-CoV-2: structural dependence of the interaction of the spike S1 receptor-binding domain with heparin","volume":"120","author":"Mycroft-West","year":"2020","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.burns.2025.107518_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.101507","article-title":"The binding of heparin to spike glycoprotein inhibits SARS-CoV-2 infection by three mechanisms","volume":"298","author":"Paiardi","year":"2022","journal-title":"J Biol Chem"},{"key":"10.1016\/j.burns.2025.107518_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1373255","article-title":"The neutralizing effect of heparin on blood-derived antimicrobial compounds: impact on antibacterial activity and inflammatory response","volume":"15","author":"Cont","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.burns.2025.107518_bib12","first-page":"157","article-title":"The antimicrobial effect of heparin on common respiratory pathogens","volume":"9","author":"Zappala","year":"2007","journal-title":"Crit Care Resusc"},{"key":"10.1016\/j.burns.2025.107518_bib13","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1128\/AAC.05061-11","article-title":"In vitro analyses of the effects of heparin and parabens on Candida albicans biofilms and planktonic cells","volume":"56","author":"Miceli","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.burns.2025.107518_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/AAC.01351-12","article-title":"Antifungal lock therapy","volume":"57","author":"Walraven","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.burns.2025.107518_bib15","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1097\/00003246-200712000-00020","article-title":"Aerosolized anticoagulants ameliorate acute lung injury in sheep after exposure to burn and smoke inhalation","volume":"35","author":"Enkhbaatar","year":"2007","journal-title":"Crit Care Med"},{"key":"10.1016\/j.burns.2025.107518_bib16","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1042\/CS20070254","article-title":"Combined anticoagulants ameliorate acute lung injury in sheep after burn and smoke inhalation","volume":"114","author":"Enkhbaatar","year":"2008","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.burns.2025.107518_bib17","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/BCR.0b013e3181923bd3","article-title":"Use of nebulized heparin in the treatment of smoke inhalation injury","volume":"30","author":"Enkhbaatar","year":"2009","journal-title":"J Burn Care Res"},{"key":"10.1016\/j.burns.2025.107518_bib18","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/01.shk.0000129201.38588.85","article-title":"Aerosolized tissue plasminogen inhibitor improves pulmonary function in sheep with burn and smoke inhalation","volume":"22","author":"Enkhbaatar","year":"2004","journal-title":"Shock"},{"key":"10.1016\/j.burns.2025.107518_bib19","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/00024382-200209000-00006","article-title":"Heparin nebulization attenuates acute lung injury in sepsis following smoke inhalation in sheep","volume":"18","author":"Murakami","year":"2002","journal-title":"Shock"},{"key":"10.1016\/j.burns.2025.107518_bib20","doi-asserted-by":"crossref","first-page":"e439","DOI":"10.1097\/CCM.0b013e318298ad3a","article-title":"Antithrombin attenuates vascular leakage via inhibiting neutrophil activation in acute lung injury","volume":"41","author":"Rehberg","year":"2013","journal-title":"Crit Care Med"},{"key":"10.1016\/j.burns.2025.107518_bib21","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/00004630-199805000-00004","article-title":"Reduction in mortality in pediatric patients with inhalation injury with aerosolized heparin\/N-acetylcystine [correction of acetylcystine] therapy","volume":"19","author":"Desai","year":"1998","journal-title":"J Burn Care Rehabil"},{"key":"10.1016\/j.burns.2025.107518_bib22","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/BCR.0b013e31815f596b","article-title":"Use of inhaled heparin\/N-acetylcystine in inhalation injury: does it help?","volume":"29","author":"Holt","year":"2008","journal-title":"J Burn Care Res"},{"key":"10.1016\/j.burns.2025.107518_bib23","doi-asserted-by":"crossref","DOI":"10.1097\/GOX.0000000000000121","article-title":"Does a nebulized Heparin\/N-acetylcysteine protocol improve outcomes in adult smoke inhalation?","volume":"2","author":"Kashefi","year":"2014","journal-title":"Plast Reconstr Surg Glob Open"},{"key":"10.1016\/j.burns.2025.107518_bib24","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1177\/0897190017747143","article-title":"Nebulized heparin With N-acetylcysteine and albuterol reduces duration of mechanical ventilation in patients with inhalation injury","volume":"32","author":"McGinn","year":"2019","journal-title":"J Pharm Pr"},{"key":"10.1016\/j.burns.2025.107518_bib25","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/BCR.0000000000000439","article-title":"Outcomes following the use of nebulized heparin for inhalation injury (HIHI Study)","volume":"38","author":"McIntire","year":"2017","journal-title":"J Burn Care Res"},{"key":"10.1016\/j.burns.2025.107518_bib26","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/BCR.0b013e318198a268","article-title":"Influence of nebulized unfractionated heparin and N-acetylcysteine in acute lung injury after smoke inhalation injury","volume":"30","author":"Miller","year":"2009","journal-title":"J Burn Care Res"},{"issue":"4","key":"10.1016\/j.burns.2025.107518_bib27","doi-asserted-by":"crossref","DOI":"10.1378\/chest.132.4_MeetingAbstracts.565","article-title":"Can nebulized heparin and N-acetylcysteine reduce acute lung injury after inhalation lung insult?","volume":"132","author":"Rivero","year":"2007","journal-title":"Chest"},{"key":"10.1016\/j.burns.2025.107518_bib28","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.burns.2011.07.006","article-title":"Safety and potential anticoagulant effects of nebulised heparin in burns patients with inhalational injury at Singapore General Hospital Burns Centre","volume":"37","author":"Yip","year":"2011","journal-title":"Burns"},{"key":"10.1016\/j.burns.2025.107518_bib29","doi-asserted-by":"crossref","first-page":"894","DOI":"10.3390\/jcm9040894","article-title":"Nebulized heparin in burn patients with inhalation trauma-safety and feasibility","volume":"9","author":"Glas","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.burns.2025.107518_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcrc.2013.06.017","article-title":"Heparin\/N-acetylcysteine: an adjuvant in the management of burn inhalation injury: a study of different doses","volume":"29","author":"Elsharnouby","year":"2014","journal-title":"J Crit Care"},{"key":"10.1016\/j.burns.2025.107518_bib31","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/BCR.0B013E31802C889F","article-title":"Inhalation injury, pulmonary perturbations, and fluid resuscitation","volume":"28","author":"Endorf","year":"2007","journal-title":"J Burn Care Res"},{"key":"10.1016\/j.burns.2025.107518_bib32","first-page":"2526","article-title":"Acute respiratory distress syndrome: the Berlin Definition","volume":"307","author":"ARDS Definition Task Force","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.burns.2025.107518_bib33","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S0094-1298(20)30126-7","article-title":"Fluid volume and electrolyte changes of the early postburn period","volume":"1","author":"Baxter","year":"1974","journal-title":"Clin Plast Surg"},{"key":"10.1016\/j.burns.2025.107518_bib34","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1183\/09031936.00010206","article-title":"Weaning from mechanical ventilation","volume":"29","author":"Boles","year":"2007","journal-title":"Eur Respir J"},{"key":"10.1016\/j.burns.2025.107518_bib35","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1097\/00003246-200208000-00016","article-title":"ARDS Network. Statistical evaluation of ventilator-free days as an efficacy measure in clinical trials of treatments for acute respiratory distress syndrome","volume":"30","author":"Schoenfeld","year":"2002","journal-title":"Crit Care Med"},{"key":"10.1016\/j.burns.2025.107518_bib36","first-page":"211","article-title":"ANZICS Clinical Trials Group. End points for phase II trials in intensive care: recommendations from the Australian and New Zealand Clinical Trials Group consensus panel meeting","volume":"14","author":"Young","year":"2012","journal-title":"Crit Care Resusc"},{"key":"10.1016\/j.burns.2025.107518_bib37","first-page":"910","article-title":"American Burn Association Practice guidelines for prevention, diagnosis, and treatment of ventilator-associated pneumonia (VAP) in burn patients","volume":"30","author":"Mosier","year":"2009","journal-title":"J Burn Care Res"},{"key":"10.1016\/j.burns.2025.107518_bib38","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1177\/0962280216669183","article-title":"Optimally estimating the sample mean from the sample size, median, mid-range, and\/or mid-quartile range","volume":"27","author":"Luo","year":"2018","journal-title":"Stat Methods Med Res"},{"key":"10.1016\/j.burns.2025.107518_bib39","series-title":"Cochrane Handbook for Systematic Reviews of Intervention","first-page":"151","article-title":"Selecting studies and collecting data","author":"Higgins","year":"2008"},{"key":"10.1016\/j.burns.2025.107518_bib40","series-title":"A Self-Learning Text","first-page":"425","article-title":"Survival analysis","author":"Kleinbaum","year":"2012"},{"key":"10.1016\/j.burns.2025.107518_bib41","series-title":"Logistic, Survival, and Repeated Measures Models","first-page":"139","article-title":"Regression methods in biostatistics linear","author":"Vittinghoff","year":"2012"},{"key":"10.1016\/j.burns.2025.107518_bib42","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1164\/ajrccm.160.2.9812076","article-title":"Prevention of exercise-induced bronchoconstriction by inhaled low-molecular-weight heparin","volume":"160","author":"Ahmed","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.burns.2025.107518_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.pupt.2021.102037","article-title":"Evaluation of efficacy of nebulized low molecular weight heparin as an adjunctive extra treatment for acute mild-moderate asthma attack; a randomized clinical trial study","volume":"68","author":"Motamed","year":"2021","journal-title":"Pulm Pharm Ther"},{"key":"10.1016\/j.burns.2025.107518_bib44","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.3390\/pharmaceutics13111768","article-title":"Early effects of low molecular weight heparin therapy with soft-mist inhaler for COVID-19-induced hypoxemia: a phase IIb trial","volume":"13","author":"Erelel","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.burns.2025.107518_bib45","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.02558-22","article-title":"Inhalation of low molecular weight heparins as prophylaxis against SARS-CoV-2","volume":"13","author":"Eder","year":"2022","journal-title":"mBio"},{"key":"10.1016\/j.burns.2025.107518_bib46","first-page":"255","article-title":"Bronchoalveolar lavage and plasma Antithrombin and cytokines in inhalation and burn injury: a pilot study","volume":"10","author":"Kowal-Vern","year":"2020","journal-title":"Int J Burns Trauma"},{"key":"10.1016\/j.burns.2025.107518_bib47","doi-asserted-by":"crossref","first-page":"17","DOI":"10.5492\/wjccm.v5.i1.17","article-title":"Antithrombin in the treatment of burn trauma","volume":"5","author":"Kowal-Vern","year":"2016","journal-title":"World J Crit Care Med"},{"key":"10.1016\/j.burns.2025.107518_bib48","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1111\/jth.13283","article-title":"Coagulopathy and its management in patients with severe burns","volume":"14","author":"Glas","year":"2016","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.burns.2025.107518_bib49","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.burns.2006.06.011","article-title":"Antithrombin deficiency and its relationship to severe burns","volume":"33","author":"Niedermayr","year":"2007","journal-title":"Burns"},{"key":"10.1016\/j.burns.2025.107518_bib50","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1465-9921-13-6","article-title":"Inhibition of allergic airway responses by heparin derived oligosaccharides: identification of a tetrasaccharide sequence","volume":"13","author":"Ahmed","year":"2012","journal-title":"Respir Res"},{"key":"10.1016\/j.burns.2025.107518_bib51","doi-asserted-by":"crossref","first-page":"584","DOI":"10.3390\/ph16040584","article-title":"Low molecular weight heparin, and non-anticoagulant derivatives for the treatment of inflammatory lung disease","volume":"16","author":"Heparin","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.burns.2025.107518_bib52","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/jth.14685","article-title":"Effects of nebulized antithrombin and heparin on inflammatory and coagulation alterations in an acute lung injury model in rats","volume":"18","author":"Camprub\u00ed-Rimblas","year":"2020","journal-title":"J Thromb Haemost"}],"container-title":["Burns"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0305417925001470?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0305417925001470?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T21:07:27Z","timestamp":1773349647000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0305417925001470"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":52,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S0305417925001470"],"URL":"https:\/\/doi.org\/10.1016\/j.burns.2025.107518","relation":{},"ISSN":["0305-4179"],"issn-type":[{"value":"0305-4179","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of early administration of inhaled heparin on outcomes of smoke inhalation injury: A randomized controlled trial","name":"articletitle","label":"Article Title"},{"value":"Burns","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.burns.2025.107518","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd and ISBI. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107518"}}